Measured Wealth Private Client Group, LLC

Position in VTRS — Viatris Inc

CIK 1720235 PORTSMOUTH, NH

Back to VTRS Full portfolio

Position in VTRS

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$8,464

+$1,264 QoQ

Shares Held

533

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#776

of 1,016 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in VTRS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Measured Wealth Private Client Group, LLC holds $841,832 across 6 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc.	13,398	$549,719
2	ELAN	Elanco Animal Health Inc	9,480	$233,302
3	NBIX	Neurocrine Biosciences Inc	140	$23,595
4	HLN	Haleon plc	1,997	$18,632
5	VTRS	Viatris Inc This page	533	$8,464
6	ZTS	Zoetis Inc.	113	$8,120

All Filings in VTRS

Export CSV

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,464	533	0.0%	Shares	Sole	2026-08-10
2026-03-31	$7,200	533	0.0%	Shares	Sole	2026-05-13
2025-12-31	$6,635	533	-79.3%	Shares	Sole	2026-02-10
2025-09-30	$25,551	2,581	-75.9%	Shares	Sole	2025-11-14
2025-06-30	$95,756	10,723	-70.4%	Shares	Sole	2025-08-13
2025-03-31	$316,007	36,281	-50.5%	Shares	Sole	2025-05-12
2024-12-31	$913,394	73,365	+0.0%	Shares	Sole	2025-01-27
2024-09-30	$851,697	73,359	-0.4%	Shares	Sole	2024-10-28
2024-06-30	$783,197	73,678	+28.4%	Shares	Sole	2024-08-12
2024-03-31	$685,117	57,380	+3.4%	Shares	Sole	2024-04-18
2023-12-31	$601,216	55,514	+77.7%	Shares	Sole	2024-02-06
2023-03-31	$300,557	31,243	+36.7%	Shares	Sole	2023-05-01
2022-12-31	$254,309	22,849	—	Shares	Sole	2023-01-23
No filing history on record for this holder in this stock.